EOM147

N/A

Report date: 2025/11/28 11:08:37
NME

Base Information

Drug NameEOM147
Drug Alias NameEOM147EOM-147
ClassificationSmall molecules > Steroids
Mechanisms of ActionCalmodulin modulatorsFibroblast growth factor receptors antagonistsPlatelet-derived growth factor receptor inhibitors +[4] 
TargetsCalmodulinFibroblast growth factor receptorsPlatelet-derived growth factor receptor +[4] 
Therapy Area/IndicationsWet age-related macular degenerationMacular EdemaDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEOM Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEOM Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationMacular EdemaDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A